Accolade, Inc. (ACCD)
NASDAQ: ACCD · Real-Time Price · USD
3.162
-0.038 (-1.19%)
Nov 4, 2024, 1:04 PM EST - Market open
Accolade Employees
Accolade had 2,400 employees as of February 29, 2024. The number of employees increased by 30 or 1.27% compared to the previous year.
Employees
2,400
Change (1Y)
30
Growth (1Y)
1.27%
Revenue / Employee
$183,762
Profits / Employee
-$33,374
Market Cap
254.90M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Pulmonx | 279 |
Sight Sciences | 214 |
Codexis | 174 |
TScan Therapeutics | 154 |
Rigel Pharmaceuticals | 147 |
Acrivon Therapeutics | 61 |
Lexeo Therapeutics | 58 |
Sera Prognostics | 57 |
ACCD News
- 4 days ago - Porter Airlines Receives Another Accolade with APEX Four Star Major Airline Rating - Business Wire
- 20 days ago - Accolade Welcomes Renalogic to Trusted Partner Ecosystem - PRNewsWire
- 27 days ago - Accolade, Inc. (ACCD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Accolade Inc (ACCD) Q2 Earnings: Revenue Hits $106.4M, Beating Estimates; GAAP EPS Loss at $0.30 - GuruFocus
- 27 days ago - Accolade Announces Results for Fiscal Second Quarter 2025 - GlobeNewsWire
- 4 weeks ago - Accolade Inc (ACCD) Q2 2025: Everything You Need to Know Ahead of Earnings - GuruFocus
- 4 weeks ago - Top Wall Street Forecasters Revamp Accolade Price Expectations Ahead Of Q2 Earnings - Benzinga
- 6 weeks ago - Accolade to Announce Fiscal Second Quarter 2025 Financial Results - GlobeNewsWire